← Back to Search

Corticosteroid

Dexamethasone for Sudden Hearing Loss

Phase 2
Waitlist Available
Led By Stephen P Cass, MD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 1 week, 1 month, 3 months
Awards & highlights

Study Summary

This trial compares hearing outcomes between dexamethasone and prednisone for people with sudden sensorineural hearing loss.

Eligible Conditions
  • Sudden Hearing Loss

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 1 week, 1 month, 3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 1 week, 1 month, 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Hearing Threshold (Hearing Improvement)
Secondary outcome measures
Changes in Pure Tone Averages
Changes in Word Recognition Scores
Clinical Frequency Analysis Based on Hearing Improvement
+1 more

Trial Design

2Treatment groups
Active Control
Group I: DexamethasoneActive Control1 Intervention
All subject identification (ID) numbers will be randomly assigned to the dexamethasone or the prednisone arm of the trial prior to the initiation of the study.
Group II: PrednisoneActive Control1 Intervention
All subject ID numbers will be randomly assigned to the dexamethasone or the prednisone arm of the trial prior to the initiation of the study.

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,544 Total Patients Enrolled
Stephen P Cass, MDPrincipal InvestigatorUniversity of Colorado, Denver

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to sign up for this clinical trial?

"Eligibility requirements for this trial include deafness and being between 18-80 years old. Up to 208 people will be accepted in total."

Answered by AI

Why is Prednisone given to patients so often?

"Prednisone has been shown to be an effective at treating ophthalmia, sympathetic, branch retinal vein occlusion, and macular edema."

Answered by AI

How many people can enroll in this clinical trial at maximum capacity?

"That is correct. The website clinicaltrials.gov has updated information which suggests that the clinical trial is still recruiting patients. This specific trial was first posted on 8/30/2017 and was last edited on 8/26/2021. They are enrolling a total of 208 patients from 1 locations."

Answered by AI

Has the Federal Drug Administration cleared Prednisone for public consumption?

"While there is some data supporting its safety, as this is only a phase 2 trial, the efficacy of Prednisone has not been clinically proven. For this reason, it received a score of 2."

Answered by AI

Can new patients join this clinical trial at this time?

"The study is still recruiting patients, according to the most recent information on clinicaltrials.gov. The original posting date was 8/30/2017, and the page was last edited on 8/26/2021."

Answered by AI

Does this research project test individuals who are over 35 years old?

"According to the study's guidelines, any person aged 18-80 is eligible to participate."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
High Dose Oral Steroids in Sudden Sensorineural Hearing Loss
2017. "High Dose Oral Steroids in Sudden Sensorineural Hearing Loss". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03255473.
~1 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top